Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   PHYSIOLOGY AND PHARMACOLOGY   SPRING 2010 , Volume 14 , Number 1; Page(s) 34 To 40.
 
Paper: 

EFFECT OF INTRACEREBROVENTRICULAR INJECTION OF FLUNIXIN MEGLUMINE ON PTZ-INDUCED SEIZURES IN MALE RATS

 
 
Author(s):  GARAVAND S., KERAMATI K., ZENDEHDEL MORTEZA*, JADIDOLESLAMI M., GARAVAND SEDIGHEH
 
* SECTION OF PHYSIOLOGY, DEPARTMENT OF BASIC SCIENCES, FACULTY OF VETERINARY MEDICINE, UNIVERCITY OF TEHRAN, TEHRAN, IRAN
 
Abstract: 

Introduction: Flunixin Meglumine (FM) is a nonsteroidal antiinflammatory drug (NSAID) and nonselective cyclooxygenase (COX) inhibitor. Since it has been suggested that COX enzyme plays a role in seizure, this research is performed to assess the therapeutic effects that this compound might have in seizures induced by PTZ.
Methods: In this research, male wistar rats (200
± 20 g) were given intracerebroventricular injections of saline or FM (12.5 mg, 25 mg and 50 mg) in a 1 ml volume, before intraperitoneal administration of PTZ (80 mg/kg) for induction of seizure. Then, seizure score and times of onset for every stage of seizure were recorded during 20 minutes after PTZ administration. The data were analyzed by one-way analysis of variance (ANOVA).
Results: injection of 25 and 50
mg of FM significantly increased times of onset of every seizure stage compared to the control group. The group that received 50 mg of FM did not show stage 5. On the other hand, 12.5 mg FM group did not show any significant difference with the control group.
Conclusion: We conclude that FM has dose dependent anticonvulsive properties.

 
Keyword(s): EPILEPSY, FLUNIXIN MEGLUMINE, PTZ, COX
 
References: 
  • ندارد
 
  Persian Abstract Yearly Visit 65
 
Latest on Blog
Enter SID Blog